Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Non Small Cell Lung Cancer Metastatic × Temozolomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 8 Recurrence 3 Astrocytoma 3 Gliosarcoma 2 Spinal Cord Neoplasms 1 Pituitary Neoplasms 1 Oligodendroglioma 1 Non Small Cell Lung Cancer Metastatic 1 Melanoma 1 Medulloblastoma 1 Glioma 1 Ependymoma 1 Brain Neoplasms 1

Interventions

Temozolomide 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03732482 2019-01-29

Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases

Taizhou Hospital

Phase 2/3 Unknown

Non Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡